Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics. - Wikidata - wikimedia - TriplyDB

Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.

Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.

http://www.wikidata.org/entity/Q38577297

about

Potential applications and human biosafety of nanomaterials used in nanomedicine Experimental estimation and analysis of variance of the measured loss power of magnetic nanoparticles.Plant viruses and bacteriophages for drug delivery in medicine and biotechnology.Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges.Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo.Dual-Cross-Linked Methacrylated Alginate Sub-Microspheres for Intracellular Chemotherapeutic Delivery.Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening.An optimised spectrophotometric assay for convenient and accurate quantitation of intracellular iron from iron oxide nanoparticles.Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles.Lipid nanocapsules formulation and cellular activities evaluation of a promising anticancer agent: EAPB0503.Nanoparticle architecture preserves magnetic properties during coating to enable robust multi-modal functionality

P2860

Q32944368-E210AA0A-9AE2-46B7-AE16-24EFDBA1DAB0 Q38656439-3B32AFD1-46C2-40A1-AC46-69BA7DEDE7FC Q38828420-64BE3FBE-8931-4471-8BE8-3892CC1CF3E7 Q38899902-CE590578-A500-40E0-9E3D-9E882C8F3FD4 Q39113994-12C12B15-290E-488E-AE61-83F65741E07E Q39485731-77C9ED7F-A4ED-45AD-AE12-9F9FED5611F3 Q42060427-72DEB9D5-A13E-44C9-837D-A06D81232B68 Q46914962-1D21274E-AF5E-4EB0-BB99-E3C0FED19A77 Q47864279-08B3BBFF-D7EC-4DC7-8F3E-1093882D13DC Q52348564-2CE4993F-72BA-4607-A090-3ABEB833CFD3 Q55128802-49A5BCAF-CAAB-44A8-A6F9-0430DA3FB68C Q58714155-9DD47971-D041-4077-8F69-EB3881A5BE80

P2860

Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.

http://www.wikidata.org/entity/Q38577297

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.

@en

type

label

Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.

@en

prefLabel

Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.

@en

P1433

Q38577297-18809700-E2FC-4557-AE44-2D69650CF587

P1476

Q38577297-0D5BD2A8-6214-4C99-899E-DF1981253683

P2093

Q38577297-06248DA4-8FBF-4748-BA24-4F43D08A0B1E

Q38577297-84DEB3E9-58C0-4533-81F2-1324A4BC85FD

Q38577297-AD9594A5-383C-41E7-A91C-BA4CB188CB95

Q38577297-D0B289D6-4557-42A5-97D6-BB62FBDF52E5

Q38577297-EB012FFB-DE2E-4B6D-95CB-34A81AE30593

P2860

Q38577297-044C29F7-895D-40BA-AA24-8BE916DB07D1

Q38577297-09AD1DF6-DC12-42A3-B3FF-D610074C2722

Q38577297-0AD76716-77CE-4520-9332-2A1131C248A5

Q38577297-108662E8-A02A-4997-A861-B0B62B4123B2

Q38577297-121AF9C6-0BF5-48B2-B64E-607B16BEC7C1

Q38577297-145B8C3A-520D-49DE-AF83-DF8F4BBF9372

Q38577297-19F43B14-6701-41A9-8196-997BA7C46BFE

Q38577297-1F1E9200-B100-462B-AA96-AF51FECA826E

Q38577297-20547FBE-C363-4429-9866-396F9DEFD5F0

Q38577297-2706EF04-0738-4842-A922-EDC2AA5F960E

P2888

Q38577297-D8F8DE2B-622C-46D0-8F85-FEE684AE1654

P304

Q38577297-3467C059-59F8-470F-B4D9-C8BD9C0E3047

P31

Q38577297-406C2DEF-8F18-48C2-8339-2F858DADB9B2

P356

Q38577297-5C4830B4-502A-4620-AD5A-EADA25542741

P433

Q38577297-93451399-F422-4956-AB17-1299FBF87571

P478

Q38577297-4A6FC995-0AAF-4F44-B3B9-1DBC370FF21C

P577

Q38577297-1E9340A0-428E-4E41-B077-5DFBDA3F792A

P6179

Q38577297-29881997-1924-439A-8520-B0182E36F532

P698

Q38577297-F2A6093D-EC1C-40EB-89E2-07E735A8EC36

P921

Q38577297-29B2FCF0-DBA9-42ED-8FF2-4EC8F43803FD

P356

S40265-015-0453-3

P1433

P1476

Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.

@en

P2093

Amélie El Hor

http://www.w3.org/2001/XMLSchema#string

Lina Bezdetnaya

http://www.w3.org/2001/XMLSchema#string

Marie Millard

http://www.w3.org/2001/XMLSchema#string

Sophie Marchal

http://www.w3.org/2001/XMLSchema#string

Véronique Gillon

http://www.w3.org/2001/XMLSchema#string

P2860

Liposomes as nanomedical devices

Pegaspargase: a review of clinical studies

Cytotoxicity of nanoparticles

Polymeric micelles in anticancer therapy: targeting, imaging and triggered release.

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.

Phase IIa trial of trastuzumab emtansine with pertuzumab for patients with human epidermal growth factor receptor 2-positive, locally advanced, or metastatic breast cancer.

SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice.

A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer

Impact of albumin on drug delivery--new applications on the horizon.

Nanomedicine(s) under the microscope.

P2888

s40265-015-0453-3

P304

1601-1611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-015-0453-3

http://www.w3.org/2001/XMLSchema#string

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1004815047

http://www.w3.org/2001/XMLSchema#string

P698

26323338

http://www.w3.org/2001/XMLSchema#string

P921